The histologic diagnosis of the remaining 6 entities (Supplementary Table 5) were discordant with the final diagnosis according to the latest WHO classification: 2 SMZL (3%), 1 ENMZL (1.5%), 1 (1.5%) follicular lymphoma (FL), 1 LPL (1.5%), 1 (1.5%) B-lymphoblastic leukemia/lymphoma (B-LBL) and 1 (1.5%) Angioimmunoblastic T-cell lymphoma (AITL). The gene discussed is LPL; the disease is follicular lymphoma.